During the past decade, Tokushima Red Cross Hospital conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 4 clinical trials were completed, i.e. on average, 133.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 4 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Tokushima Red Cross Hospital" #1 collaborator was "Abbott" with 1 trials as a collaborator and "Medtronic" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Tokushima Red Cross Hospital" are "Coronary Artery Disease" (3 trials), "Myocardial Ischemia" (3 trials), "Angina Pectoris" (2 trials), "Ischemic Heart Disease" (2 trials) and "Aortic Stenosis" (1 trials). Many other conditions were trialed in "Tokushima Red Cross Hospital" in a lesser frequency.

Most popular intervention types in "Tokushima Red Cross Hospital" are "Device" (5 trials). Other intervention types were less common.

The name of intervention was led by "17mm MDT-2215 aortic valve bioprosthesis" (1 trials), "Absorb™ BVS" (1 trials), "MitraClip NT System" (1 trials), "XIENCE PRIME SV Everolimus Eluting Coronary Stent" (1 trials) and "XIENCE PRIME®/XIENCE Xpedition™" (1 trials). Other intervention names were less common.

The vast majority of trials in "Tokushima Red Cross Hospital" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Tokushima Red Cross Hospital". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Tokushima Red Cross Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Tokushima Red Cross Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".